Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Karen Bräutigam"'
Publikováno v:
Infectious Diseases in Obstetrics and Gynecology, Vol 2024 (2024)
Conclusion: The HPV L1 high-risk specific serological lateral flow rapid test shows promising data in the field of early detection of HPV high-risk induced cervical cancer and its precursor lesions. This easy-to-use, robust, and affordable approach c
Externí odkaz:
https://doaj.org/article/7e31b41902aa4f05a4d7c590bbef5fbe
Autor:
Karen Bräutigam, Stefanie Meier, Sabina Meneder, Louisa Proppe, Katharina Stroschein, Stephan Polack, Frank Köster, Achim Rody, Sascha Baum
Publikováno v:
Cancers, Vol 14, Iss 13, p 3136 (2022)
Background: Cancers and intraepithelial lesions of different anogenital areas as well as oral cancer are associated with human papilloma virus (HPV) infections. Methods: In this study cervical, vaginal, vulvar, anal, and oral samples were taken from
Externí odkaz:
https://doaj.org/article/a06d90045f8b4277a7e77052fdffb2dd
Autor:
Ahmad Fawzi Hussain, Armin Grimm, Wenjie Sheng, Chaoyu Zhang, Marwah Al-Rawe, Karen Bräutigam, Mobarak Abu Mraheil, Felix Zeppernick, Ivo Meinhold-Heerlein
Publikováno v:
Pharmaceuticals, Vol 14, Iss 4, p 343 (2021)
In the last few decades, antibody-based diagnostic and therapeutic applications have been well established in medicine and have revolutionized cancer managements by improving tumor detection and treatment. Antibodies are unique medical elements due t
Externí odkaz:
https://doaj.org/article/338f45bbaee44ee3b2876280d3996451
Autor:
Garret M. Hampton, Norbert Arnold, Walter Jonat, Thomas Bauknecht, Jacobus Pfisterer, Constantin S. von Kaisenberg, Felix Hilpert, Dominique Könsgen, Elmar Stickeler, Jalid Sehouli, Karen Bräutigam, Henry Frierson, Keith Ching, Lisa M. Sapinoso, Yingyao Zhou, Dirk Bauerschlag, Ivo Meinhold-Heerlein
Purpose: Cancer of the ovary confers the worst prognosis among women with gynecologic malignancies, underscoring the need to develop new biomarkers for detection of early disease, particularly those that can be readily monitored in the blood.Experime
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46f39197618423135628be73bdcd745d
https://doi.org/10.1158/1078-0432.c.6517699
https://doi.org/10.1158/1078-0432.c.6517699
Autor:
Garret M. Hampton, Norbert Arnold, Walter Jonat, Thomas Bauknecht, Jacobus Pfisterer, Constantin S. von Kaisenberg, Felix Hilpert, Dominique Könsgen, Elmar Stickeler, Jalid Sehouli, Karen Bräutigam, Henry Frierson, Keith Ching, Lisa M. Sapinoso, Yingyao Zhou, Dirk Bauerschlag, Ivo Meinhold-Heerlein
Supplementary Tables S1-S2 from An Integrated Clinical-Genomics Approach Identifies a Candidate Multi-Analyte Blood Test for Serous Ovarian Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0715a00031087a92225dc5fc891f28b6
https://doi.org/10.1158/1078-0432.22440361.v1
https://doi.org/10.1158/1078-0432.22440361.v1
Autor:
Frank Köster, S. Polack, Achim Rody, Elodie Kabore-Wolff, Karen Bräutigam, Lars Hanker, Ahmad Fawzi Hussain
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Purpose Triple-negative breast cancer (TNBC) is characterized by an unfavorable prognosis and missing systemic therapeutic approaches beside chemotherapy. Targeting the immune checkpoint PD-1/PD-L1 showed promising results in breast cancer and especi
Autor:
Karen Bräutigam, Elodie Kabore-Wolff, Ahmad Fawzi Hussain, Stephan Polack, Achim Rody, Lars Hanker, Frank Köster
Purpose: Triple negative breast cancer (TNBC) is characterized by an unfavorable prognosis and missing systemic therapeutic approaches beside chemotherapy. Targeting the immune checkpoint PD-1/PD-L1 showed promising results in breast cancer and espec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::486816c8929bdd02e072d899d754e5d9
https://doi.org/10.21203/rs.3.rs-466719/v1
https://doi.org/10.21203/rs.3.rs-466719/v1
Autor:
Achim Rody, Constanze Banz‑Jansen, Friederike Hoellen, Frank Köster, Julika Ribbat‑Idel, Karen Bräutigam, Lisa Sauer
Publikováno v:
Oncology Letters
In the current retrospective cohort study, the expression of the Proteasome 26S non-ATPase Subunit 9 (PSMD9) was investigated in 102 patients with cervical cancer. The rat homologue of PSMD9, Bridge-1, was identified as a binding protein of the trans
Autor:
Maximilian Klar, Claudia Ehret, Achim Rody, Verena Schillinger, Karen Bräutigam, Frank Köster, Marcus Panning, Sascha Baum
Publikováno v:
Archives of gynecology and obstetrics. 301(3)
Human papilloma virus (HPV) as the most common viral infection of the anogenital tract is highly associated with intraepithelial neoplasia and cancer of the cervix and other anogential regions. To date, 15 high-risk (HR-) HPV and 3 probably/possibly
Autor:
Dirk, Bauerschlag, Ivo, Meinhold-Heerlein, Nicolai, Maass, Andreas, Bleilevens, Karen, Bräutigam, Wa'el, Al Rawashdeh, Stefano, Di Fiore, Anke Maria, Haugg, Felix, Gremse, Julia, Steitz, Rainer, Fischer, Elmar, Stickeler, Stefan, Barth, Ahmad Fawzi, Hussain
Publikováno v:
Pharmaceutical research. 34(4)
Targeted theranostics is an alternative strategy in cancer management that aims to improve cancer detection and treatment simultaneously. This approach combines potent therapeutic and diagnostic agents with the specificity of different cell receptor